EE251 A Budget Impact Analysis of the Introduction of Generics Ambrisentan and Tadalafil for the Treatment of Pulmonary Arterial Hypertension in Greece
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.499
https://www.valueinhealthjournal.com/article/S1098-3015(22)02703-6/fulltext
Title :
EE251 A Budget Impact Analysis of the Introduction of Generics Ambrisentan and Tadalafil for the Treatment of Pulmonary Arterial Hypertension in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02703-6&doi=10.1016/j.jval.2022.09.499
First page :
Section Title :
Open access? :
No
Section Order :
10031